🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being done to look at how tucatinib could affect the way othe...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2018-09-17
Trial ID
NCT03723395
Treatments Being Tested
Evaluate the Effect of Ripretinib on the Pharmacokinetics of a CYP2C8 Subst...
Status
Completed
Location
Mayo Clinic Florida
Start Date
2021-09-22
Trial ID
NCT04530981
Treatments Being Tested
This is a 17 week, randomized, single center, open-label, parallel-group st...
Status
Unknown
Location
PLA General Hospital
Start Date
2009-01
Trial ID
NCT00832481
Treatments Being Tested
A Phase I, Open-label, Fixed-sequence, Crossover, Drug-drug Interaction Stu...
Status
Completed
Location
Volunteer recruitment center Covance Leeds Covance Leeds
Start Date
2020-11-10
Trial ID
NCT04643249
Treatments Being Tested
The purpose of the study is to clarify whether patients classified as Laten...
Status
Completed
Location
Valdemar Grill
Start Date
2009-03
Trial ID
NCT01140438
Treatments Being Tested
This study is conducted in Asia. The aim of this study is to review the saf...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2001-08-30
Trial ID
NCT01498913
Treatments Being Tested
Phase 1/2, dose escalation and expansion study designed to evaluate the saf...
Status
Recruiting
Location
University of California Irvine Medical Center
Start Date
2022-06-09
Trial ID
NCT05384626
Treatments Being Tested
This trial is conducted in the United States of America (USA). This trial c...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2006-11
Trial ID
NCT00399711
Treatments Being Tested
The main purpose of this study is to evaluate the effect of pirtobrutinib (...
Status
Completed
Location
Covance Clinical Research Unit
Start Date
2020-11-10
Trial ID
NCT06165146
Treatments Being Tested
This study will evaluate the effects of nirogacestat 100 mg twice daily (BI...
Status
Completed
Location
ICON Martini Groningen CRU
Start Date
2025-10-27
Trial ID
NCT07259330
Treatments Being Tested